Oppenheimer Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-26,043
Closed -$1.88M – 1215
2022
Q1
$1.88M Sell
26,043
-243
-0.9% -$17.5K 0.03% 553
2021
Q4
$2.41M Sell
26,286
-1,044
-4% -$125K 0.03% 497
2021
Q3
$3.47M Buy
27,330
+310
+1% +$45.1K 0.05% 376
2021
Q2
$4.49M Buy
27,020
+9,539
+55% +$1.55M 0.06% 320
2021
Q1
$3.18M Sell
17,481
-31,588
-64% -$7.33M 0.05% 379
2020
Q4
$9.81M Buy
49,069
+511
+1% +$104K 0.16% 159
2020
Q3
$10.6M Sell
48,558
-5,152
-10% -$1.09M 0.21% 124
2020
Q2
$10.2M Sell
53,710
-5,514
-9% -$966K 0.21% 122
2020
Q1
$9.18M Sell
59,224
-11,571
-16% -$1.35M 0.23% 113
2019
Q4
$5.93M Sell
70,795
-2,686
-4% -$204K 0.13% 197
2019
Q3
$4.98M Sell
73,481
-1,332
-2% -$87.7K 0.11% 222
2019
Q2
$4.97M Buy
74,813
+5,133
+7% +$299K 0.11% 226
2019
Q1
$3.87M Buy
69,680
+34,852
+100% +$2.13M 0.09% 258
2018
Q4
$1.73M Buy
34,828
+25,039
+256% +$1.53M 0.04% 398
2018
Q3
$845K Buy
9,789
+862
+10% +$61.4K 0.02% 663
2018
Q2
$518K Buy
8,927
+517
+6% +$25.3K 0.01% 788
2018
Q1
$339K Buy
+8,410
New +$317K 0.01% 897
2017
Q4
– Sell
-4,936
Closed -$164K – 1444
2017
Q3
$164K Buy
4,936
+140
+3% +$4.59K ﹤0.01% 1089
2017
Q2
$166K Buy
+4,796
New +$140K ﹤0.01% 1077

Other funds holding TDOC

Oppenheimer Asset Management's TDOC Position: Q2 2022 in Review

Oppenheimer Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 26,043 shares — an estimated $1.88M sold.

Oppenheimer Asset Management first reported a position in TDOC in Q2 2017 and held it in 19 quarters. The position peaked at $10.6M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Oppenheimer Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 26,043 Teladoc Health shares in Q2 2022, an estimated $1.88M.
  • Oppenheimer Asset Management first reported a position in Teladoc Health in Q2 2017 and held it in 19 quarters.
  • Oppenheimer Asset Management's Teladoc Health position peaked at $10.6M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.